Literature DB >> 23033920

Regulation of JAK2 activation by Janus homology 2: evidence from molecular dynamics simulations.

Shunzhou Wan1, Peter V Coveney.   

Abstract

Janus kinase 2 (JAK2) is a protein tyrosine kinase implicated in signaling by specific members of the cytokine receptor family. Although it has been established that the JAK2 tyrosine kinase is negatively regulated by the JAK homology 2 (JH2) pseudokinase domain, the underlying mechanism of JH2 mediated regulation remains elusive. To elucidate the regulation of JAK2 kinase, we have built a structural model for the kinase and pseudokinase domains of JAK2. An asymmetric dimer is proposed, in which the kinase domain JH1 occupies a position where it could not be activated. We investigate the dynamic and energetic properties of the dimer by molecular dynamics simulation. JAK2 activation requires the two domains to be dissociated and rearranged in a form such that the JH1 kinase domain can adopt an active conformation. The significance of the above mechanism is emphasized by the finding that the activating V617F mutation destabilizes JH1-JH2 association in the proposed asymmetric dimer. Thus abrogation of the domain-domain interaction seems to be a possible first step for the structural rearrangement of the two domains, resulting in constitutive activation of JAK2 by the V617F mutation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033920     DOI: 10.1021/ci300308g

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  4 in total

1.  Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.

Authors:  Yibing Shan; Kavitha Gnanasambandan; Daniela Ungureanu; Eric T Kim; Henrik Hammarén; Kazuo Yamashita; Olli Silvennoinen; David E Shaw; Stevan R Hubbard
Journal:  Nat Struct Mol Biol       Date:  2014-06-11       Impact factor: 15.369

Review 2.  JAK2 activation by growth hormone and other cytokines.

Authors:  Michael J Waters; Andrew J Brooks
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

3.  3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells.

Authors:  Hui Shan; Sheng Yao; Yang Ye; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2019-06-14       Impact factor: 6.150

4.  Targeted sequencing of candidate gene regions for myelofibrosis in dogs.

Authors:  Amelia G Campbell; Davis M Seelig; Joan D Beckman; Katie M Minor; Daniel A Heinrich; Steven G Friedenberg; Jaime F Modiano; Eva Furrow
Journal:  J Vet Intern Med       Date:  2022-07-11       Impact factor: 3.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.